Leukemia Clinical Trials

Showing 1421-1440 of 10,987 trials

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

NCT05424731

This is an open label expanded access program for male and female patients 2 years or older, to provide continued desensitization treatment with DBV712 250 mcg.

Peanut Allergy

DBV Technologies

Madison, Connecticut, United States

RECRUITINGPhase 2

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

NCT06648889

The planned trial offers treatment cohorts for patients with full cytologic relapse (R/R ALL - Cohort 1), as well as for patients with molecular failure/relapse (MRD+ ALL - Cohort 2). Basically, the study aims to develop data for optimization of first-line therapy of T-ALL, either by modification of standard induction with Isatuximab or by establishing a post-induction therapy for eradication of MRD and thereby evaluates in parallel two different strategies.

T-ALL

Goethe University40 participantsStarted Oct 2024

Augsburg, Germany • Berlin, Germany • Dresden, Germany +11 more locations

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

Related Searches

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

SL-28 for Advanced Solid Tumours

A Study of DM005 in Patients With Advanced Solid Tumors

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy

Removing Transfusion Dependence as a Barrier to Hospice Enrollment

The Effect of Hemsball in the Older People

Registry Study of Cerebral Small Vessel Disease

Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Gastric Content Ultrasound Monitoring Prior to Extubation in Critically Ill Children

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Fluid Balance in Acute Kidney Injury in Critically Ill Patients